Masimo Corp (MASI)
169.12
+4.17
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
169.21
+0.09
(+0.05%)
After-Hours: 20:00
Masimo Enterprise Value: 9.669B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 21, 2024 | 9.669B |
November 20, 2024 | 9.446B |
November 19, 2024 | 9.368B |
November 18, 2024 | 9.225B |
November 15, 2024 | 9.238B |
November 14, 2024 | 9.189B |
November 13, 2024 | 9.271B |
November 12, 2024 | 9.226B |
November 11, 2024 | 9.268B |
November 08, 2024 | 9.310B |
November 07, 2024 | 9.253B |
November 06, 2024 | 9.589B |
November 05, 2024 | 8.729B |
November 04, 2024 | 8.505B |
November 01, 2024 | 8.336B |
October 31, 2024 | 8.324B |
October 30, 2024 | 8.265B |
October 29, 2024 | 8.166B |
October 28, 2024 | 8.148B |
October 25, 2024 | 8.074B |
October 24, 2024 | 8.149B |
October 23, 2024 | 8.216B |
October 22, 2024 | 8.309B |
October 21, 2024 | 8.327B |
October 18, 2024 | 8.359B |
Date | Value |
---|---|
October 17, 2024 | 8.268B |
October 16, 2024 | 8.354B |
October 15, 2024 | 8.320B |
October 14, 2024 | 8.343B |
October 11, 2024 | 8.143B |
October 10, 2024 | 8.216B |
October 09, 2024 | 8.297B |
October 08, 2024 | 8.107B |
October 07, 2024 | 7.878B |
October 04, 2024 | 8.047B |
October 03, 2024 | 7.704B |
October 02, 2024 | 7.871B |
October 01, 2024 | 7.810B |
September 30, 2024 | 7.753B |
September 27, 2024 | 7.774B |
September 26, 2024 | 7.769B |
September 25, 2024 | 7.805B |
September 24, 2024 | 7.399B |
September 23, 2024 | 7.336B |
September 20, 2024 | 7.144B |
September 19, 2024 | 6.626B |
September 18, 2024 | 6.764B |
September 17, 2024 | 6.802B |
September 16, 2024 | 6.746B |
September 13, 2024 | 6.684B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.870B
Minimum
Oct 16 2023
16.10B
Maximum
Nov 19 2021
9.732B
Average
8.929B
Median
Mar 31 2020
Enterprise Value Benchmarks
Boston Scientific Corp | 143.48B |
Baxter International Inc | 28.43B |
Intuitive Surgical Inc | 191.98B |
Tandem Diabetes Care Inc | 1.894B |
Glaukos Corp | 7.559B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 9.80M |
Revenue (Quarterly) | 504.60M |
Total Expenses (Quarterly) | 474.50M |
EPS Diluted (Quarterly) | 0.18 |
Gross Profit Margin (Quarterly) | 52.16% |
Profit Margin (Quarterly) | 1.94% |
Earnings Yield | 0.86% |
Operating Earnings Yield | 1.71% |
Normalized Earnings Yield | 1.160 |